Delivery Order SPE2DB22D3501-SPE2DB25FTL19

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTL19
    Delivery Order

This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTL19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,045.15 firm fixed-price delivery order is for the supply of MVASI 400 MG/16 ML VIAL 16ML, a medical product.

The award is not designated with any set-aside requirements, indicating it was competitively awarded. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

These contracts demonstrate AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, by leveraging its extensive supply chain and distribution capabilities to deliver a wide array of critical pharmaceutical and medical products.

Generated 2/7/25, 9:03 AM